Aptamers find applications in clinical diagnostics, separations, purifications, affinity reagents for analyte detection and isolation, sensor development, and drug delivery. They offer advantages such as shorter development times, cost effectiveness, and high specificity and affinity for targets.

 

The global Aptamers Market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market key trends:

The increasing investment in research and development of aptamers by biotechnology and pharmaceutical companies is the major factor driving the growth of the aptamers market. For instance, as per the report published by National Institutes of Health (NIH), in United States the total funding for aptamers research has increased from US$ 80 million in 2018 to US$ 120 million in 2021. Also, NIH projected aptamers research funding to reach US$ 150 million by 2025. This increasing investment is emphasizing on the development of novel aptamers for diagnostic, therapeutic and other applications which is expected to boost the market growth over the forecast period.

 

Segment Analysis

The global aptamers market is dominated by diagnostics segment. Aptamers bind with high affinity and specificity to molecular targets such as proteins, peptides, toxins, dye molecules, pathogens to study their functions and detect biomarkers. This property makes them suitable for diagnostic applications such as disease detection and monitoring. Currently, aptamers are widely used for the detection of cancer biomarkers, toxins, and protein biomarkers of infectious diseases. Owing to increasing cases of chronic and infectious diseases, the diagnostics segment is expected to dominate the market during the forecast period.

 

Key Takeaways

The Global Aptamers Market Size is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030.

 

Regional analysis: North America region is expected to dominate the global aptamers market during the forecast period. Presence of major players, high R&D investments, growing demand for personalized medicine, and rising research in aptamer therapeutics and diagnostics drive the market growth in this region.

 

Key players: Key players operating in the Aptamers market are ContiTech Australia Pty. Ltd., Endless Belt Service Pty Ltd., Fenner Dunlop Australia Pty Ltd, Flexible Steel Lacing Company (Flexco), Kinder Australia Pty Ltd., Mato GmbH & Co. KG., Minprovise Pty Ltd, Nepean Engineering & Innovation Pty Ltd., Reliable Conveyor Belt Pty. Ltd., Rema Tip Top Australia, Forbo Siegling PTY. Ltd., and others. Major players are focused on product innovation, partnerships and collaborative agreements to strengthen their market position.


Get More Insights Here

https://www.newswirestats.com/aptamers-market-share-size-forecast-outlook-2023-2030-2/